Potential Drug Candidate Emerges as Llama Antibodies Found to Neutralize COVID-19’s Spike Protein – Good News Network

Two nanobodiessmall, stable immune cells similar to various antibodies and derived from llamashave been found in tests to neutralize COVID-19 by blocking its interaction with the human receptor that it binds to.
The nanobodies block the attachment of the COVID-19 spike protein by targeting a region of the protein immediately adjacent to and slightly overlapping with the region of the cell where COVID-19 binds and enters. Both llama nanobodies were shown to neutralize live COVID-19, and showed particularly high potency and increased neutralization potential when combined with a human antibody. The findings were published in Nature Structural & Molecular Biology paper.
RELATED: How a Crowded Slum of One Million People Contained the Coronavirus to Only 2,000 Cases
The development of immunizations for coronaviruses is a well-established process. The virus possesses a protein which binds to a receptor on the exterior of the cells of an infected individual.
Like a boat docking at a wharf, the virus needs a place to ‘dock’ its spike protein, otherwise it cannot enter the cell. Therefore the first path for researchers and drug developers is to see how they can prevent the binding of the spike protein with the cell receptor.
“Although there is currently no cure or vaccine for the disease,” writes James Naismith at the The Rosalind Franklin Institute, Didcot, UK, “passive immunotherapy by transfusing critically ill COVID-19 patients with serum from

Click here to view the original article.